Drug Profile
DX 0385
Alternative Names: DX-0385Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator DermaXon
- Class Antiacnes
- Mechanism of Action Retinoic acid metabolism modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Acne in USA (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Acne in USA
- 19 Jul 2016 Preclinical trials in Acne in USA (unspecified route)